Compass Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Compass Therapeutics, Inc. has filed 349 SEC EDGAR filings since 30 May 2018

SEC filing history

Showing 76-100 of 349 matching filings.

Per page
25
Current page
4
S-8 File 333-286148

S-8

Filing date
27 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90878

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90878

SCHEDULE 13G/A filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2025
Reporting date
08 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90878

SCHEDULE 13G filing

Filing date
04 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90878

SCHEDULE 13G filing

Filing date
16 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Jan 2025
Reporting date
09 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2024
Reporting date
09 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Dec 2024
Reporting date
09 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Dec 2024
Reporting date
09 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90878

JANUS CLOSEOUT

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .